India's Sun Pharmaceuticals Ltd. (524715.BY) said Saturday it had launched an offer to buyout minority shareholders of its unit Caraco Pharmaceutical Laboratories Inc. (CPD), in a bid to delist Caraco.

The drug maker said that it had offered to pay $4.75 per share in cash in a notification to the Bombay Stock Exchange.

Caraco declared a loss in the July-to-September period, and has been facing regulatory problems over the last year, hurting Sun Pharmaceutical's U.S. sales.

-By Bijou George, Dow Jones Newswires; +91-22-6145-6111; bijou.george@dowjones.com
Caraco (AMEX:CPD)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse Caraco
Caraco (AMEX:CPD)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse Caraco